Cronos (CRON) Revenue Growth (3y) (2021 - 2026)
Cronos (CRON) Revenue Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 2.84% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 4.19% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -4.46% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 15.52% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -2.00% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 24.66% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 2.94% |
| 10 | Cronos | 1.04 Bn | 267.78 Mn | 19.15 Mn | 85.71% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 85.71% |
| Dec 31, 2025 | 45.12% |
| Sep 30, 2025 | 33.75% |
| Jun 30, 2025 | -26.41% |
| Mar 31, 2025 | -27.26% |
| Dec 31, 2024 | -35.13% |
| Sep 30, 2024 | 43.38% |
| Jun 30, 2024 | 35.28% |
| Mar 31, 2024 | 26.10% |
| Dec 31, 2023 | 24.74% |
| Sep 30, 2023 | 29.75% |
| Jun 30, 2023 | 37.69% |
| Mar 31, 2023 | -8.92% |
| Dec 31, 2022 | -98.06% |
| Sep 30, 2022 | 248.06% |
| Jun 30, 2022 | 52.41% |
| Mar 31, 2022 | 102.74% |
| Dec 31, 2021 | 14.72% |